Mankind Pharma has informed that the Nomination and Remuneration Committee of the Board of Directors of the Company vide circular resolution passed today i.e. May 10, 2024, has allotted 46,698 equity shares of face value of Re 1 each of the Company to the eligible employees who have exercised their options pursuant to Employees Stock Option Plan 2022 (ESOP 2022). These shares shall rank pari-passu with the existing equity shares of the Company. Consequent to the aforesaid allotment, the paid-up share capital of the Company has increased from 40,05,88,440 Equity Shares to 40,06,35,138 Equity Shares having face value of Re 1 each. In terms of Regulation 10(c) of the SEBI ESOP Regulations, the statutory details are enclosed as Annexure - I. The same is being uploaded on website of the Company at www.mankindpharma.com.
The above information is a part of company’s filings submitted to BSE.